Programme THURSDAY, 12 APRIL 2018

DR AND RVO

08.30 Safety of intravitreal treatments

09:15 Differences in efficacy among the intravitreal treatments for DME

09.45 Regimens of treatment and criteria for dealing with poor responders, optimize the results, and lower the burden of treatment

10:30 COFFEE BREAK

11:00 Real life data of DME intravitreal treatments and patients management

11.30 PDR treatment with anti-VEGF: beyond protocol results what is his clinical application?

12.00 Intravitreal steroids and anti-VEGF treatment of ME in RVO

12:45 LUNCH

13.45 Cases study of management and monitoring of DME

14.30 Cases study of management and monitoring of ME in RVO

15.15 Cases study of management and monitoring of PDR

16.00 – 16.45 Cases study of management and monitoring of other vascular retinopathies (Von-Hipple, Leber-Coats etc.)